Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

We describe two cases of patients with hepatitis C virus (HCV) treated with direct-acting antiviral (DAA) therapy who had dramatic improvement in hepatocellular carcinoma (HCC) tumor burden with DAA therapy alone. Both patients were diagnosed with HCC on screening magnetic resonance imaging shortly...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffith, Anna S, Hayashi, Paul H, Burke, Lauren MB, McRee, Autumn J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987785/
https://www.ncbi.nlm.nih.gov/pubmed/29911076
http://dx.doi.org/10.2147/JHC.S152569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987785/
https://www.ncbi.nlm.nih.gov/pubmed/29911076
http://dx.doi.org/10.2147/JHC.S152569

Ejemplares similares